RAD9B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.268000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.972000E-02
Normal-vs-Stage2
2.291800E-01
Normal-vs-Stage3
1.374030E-01
Normal-vs-Stage4
7.834000E-02
Stage1-vs-Stage2
6.736200E-01
Stage1-vs-Stage3
1.040350E-01
Stage1-vs-Stage4
4.389800E-01
Stage2-vs-Stage3
3.966400E-02
Stage2-vs-Stage4
4.200600E-01
Stage3-vs-Stage4
2.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.318000E-01
Normal-vs-AfricanAmerican
5.447800E-02
Normal-vs-Asian
1.903400E-01
Caucasian-vs-AfricanAmerican
6.959400E-01
Caucasian-vs-Asian
2.054200E-01
AfricanAmerican-vs-Asian
6.053400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.252000E-01
Normal-vs-Female
2.290400E-01
Male-vs-Female
8.394400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.739200E-01
Normal-vs-Age(41-60Yrs)
2.187800E-01
Normal-vs-Age(61-80Yrs)
2.278000E-01
Normal-vs-Age(81-100Yrs)
2.181900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.447960E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.417800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.810600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.111200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.971600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.517800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.230600E-01
Normal-vs-Daily Drinker
2.226800E-01
Normal-vs-Weekly Drinker
1.771550E-02
Normal-vs-Occasional Drinker
2.310000E-01
Normal-vs-Social Drinker
2.525600E-01
Non Drinker-vs-Daily Drinker
9.624600E-01
Non Drinker-vs-Weekly Drinker
8.965200E-01
Non Drinker-vs-Occasional Drinker
7.566800E-01
Non Drinker-vs-Social Drinker
5.669800E-01
Daily Drinker-vs-Weekly Drinker
8.772800E-01
Daily Drinker-vs-Occasional Drinker
7.486200E-01
Daily Drinker-vs-Social Drinker
5.754600E-01
Weekly Drinker-vs-Occasional Drinker
9.397200E-01
Weekly Drinker-vs-Social Drinker
7.334000E-01
Occasional Drinker-vs-Social Drinker
7.058600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.096600E-01
Normal-vs-Grade 2
8.993800E-02
Normal-vs-Grade 3
1.145420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.742000E-01
Grade 1-vs-Grade 3
1.009190E-01
Grade 1-vs-Grade 4
3.096600E-01
Grade 2-vs-Grade 3
2.101200E-01
Grade 2-vs-Grade 4
8.993800E-02
Grade 3-vs-Grade 4
1.145420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.081400E-01
Normal-vs-NonDiabetic
2.299400E-01
Diabetic-vs-NonDiabetic
2.846800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.128200E-01
Normal-vs-NoPancreatitis
2.246200E-01
Pancreatitis-vs-NoPancreatitis
6.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.188200E-01
Normal-vs-N1
2.281800E-01
N0-vs-N1
6.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.407200E-01
Normal-vs-TP53-NonMutant
2.664000E-01
TP53-Mutant-vs-TP53-NonMutant
4.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
